Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HINT1 | P49773 | 1/20 | 0.45 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | NT5E | P21589 | 2/20 | 0.39 |
| ▸ | KRAS | P01116 | 8/20 | 0.39 |
| ▸ | FUT6 | P51993 | 1/20 | 0.39 |
| ▸ | TGM2 | P21980 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13523361 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL15215805 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL13522466 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL10819846 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL12758246 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL12202712 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL12149834 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL3132403 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL13522420 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E | |
| SCHEMBL12202710 | 1.00 | HINT1 (0.45) | HINT1TAS1R3TAS1R1ADORA3NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7951789-B2 | Compounds and pharmaceutical compositions for the treatment of viral infections | IDENIX PHARMACEUTICALS, INC. (US) | 2011-05-31 | — | — | US | disclosed |